- Home
- NBTX vs AEVA Comparison
NBTX vs AEVA Comparison
Compare NBTX & AEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBTX
- AEVA
- Stock Information
- Founded
- NBTX 2003
- AEVA 2019
- Country
- NBTX France
- AEVA United States
- Employees
- NBTX N/A
- AEVA N/A
- Industry
- NBTX Biotechnology: Pharmaceutical Preparations
- AEVA Auto Parts:O.E.M.
- Sector
- NBTX Health Care
- AEVA Consumer Discretionary
- Exchange
- NBTX Nasdaq
- AEVA Nasdaq
- Market Cap
- NBTX 868.8M
- AEVA 1.0B
- IPO Year
- NBTX 2020
- AEVA N/A
- Fundamental
- Price
- NBTX $27.75
- AEVA $19.90
- Analyst Decision
- NBTX Strong Buy
- AEVA Strong Buy
- Analyst Count
- NBTX 1
- AEVA 5
- Target Price
- NBTX $8.00
- AEVA $20.80
- AVG Volume (30 Days)
- NBTX 162.1K
- AEVA 2.5M
- Earning Date
- NBTX 09-30-2025
- AEVA 11-05-2025
- Dividend Yield
- NBTX N/A
- AEVA N/A
- EPS Growth
- NBTX N/A
- AEVA N/A
- EPS
- NBTX N/A
- AEVA N/A
- Revenue
- NBTX $11,930,711.00
- AEVA $13,825,000.00
- Revenue This Year
- NBTX N/A
- AEVA $108.44
- Revenue Next Year
- NBTX $114.97
- AEVA $103.49
- P/E Ratio
- NBTX N/A
- AEVA N/A
- Revenue Growth
- NBTX N/A
- AEVA 111.39
- 52 Week Low
- NBTX $2.76
- AEVA $2.52
- 52 Week High
- NBTX $30.35
- AEVA $38.80
- Technical
- Relative Strength Index (RSI)
- NBTX 66.10
- AEVA 60.56
- Support Level
- NBTX $23.31
- AEVA $15.46
- Resistance Level
- NBTX $29.72
- AEVA $19.70
- Average True Range (ATR)
- NBTX 2.12
- AEVA 1.67
- MACD
- NBTX 0.66
- AEVA 0.35
- Stochastic Oscillator
- NBTX 80.80
- AEVA 75.57
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
About AEVA Aeva Technologies Inc.
Aeva Technologies Inc through its Frequency Modulated Continuous Wave (FMCW) sensing technology, designs a 4D LiDAR-on-chip that, along with its proprietary software applications, has the potential to enable the adoption of LiDAR across broad applications from automated driving to consumer electronics, consumer health, industrial automation, and security application. The company operates in North America, EMEA, and Asia. The company derives the majority of its revenue from North America.